Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.

Fanelli R, Floquet N, Besserer-Offroy É, Delort B, Vivancos M, Longpré JM, Renault P, Martinez J, Sarret P, Cavelier F.

J Med Chem. 2017 Apr 27;60(8):3303-3313. doi: 10.1021/acs.jmedchem.6b01848. Epub 2017 Apr 10.

PMID:
28368584
2.

NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.

Smith KE, Boules M, Williams K, Richelson E.

Behav Brain Res. 2012 Jun 15;232(1):93-7. doi: 10.1016/j.bbr.2012.03.044. Epub 2012 Apr 5.

PMID:
22504145
3.
4.

NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.

Simeth NA, Bause M, Dobmeier M, Kling RC, Lachmann D, Hübner H, Einsiedel J, Gmeiner P, König B.

Bioorg Med Chem. 2017 Jan 1;25(1):350-359. doi: 10.1016/j.bmc.2016.10.039. Epub 2016 Nov 1.

PMID:
27842797
5.

Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.

Alshoukr F, Rosant C, Maes V, Abdelhak J, Raguin O, Burg S, Sarda L, Barbet J, Tourwé D, Pelaprat D, Gruaz-Guyon A.

Bioconjug Chem. 2009 Aug 19;20(8):1602-10. doi: 10.1021/bc900151z. Epub 2009 Jul 17.

PMID:
19610615
6.

Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.

Roussy G, Dansereau MA, Baudisson S, Ezzoubaa F, Belleville K, Beaudet N, Martinez J, Richelson E, Sarret P.

Mol Pain. 2009 Jul 6;5:38. doi: 10.1186/1744-8069-5-38.

7.

Impact of the proline residue on ligand binding of neurotensin receptor 2 (NTS2)-selective peptide-peptoid hybrids.

Held C, Hübner H, Kling R, Nagel YA, Wennemers H, Gmeiner P.

ChemMedChem. 2013 May;8(5):772-8. doi: 10.1002/cmdc.201300054. Epub 2013 Mar 26.

PMID:
23532897
8.

The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.

Smith KE, Boules M, Williams K, Fauq AH, Richelson E.

Behav Brain Res. 2011 Oct 31;224(2):344-9. doi: 10.1016/j.bbr.2011.06.014. Epub 2011 Jun 21.

9.

Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L.

Oliveros A, Heckman MG, Del Pilar Corena-McLeod M, Williams K, Boules M, Richelson E.

J Exp Biol. 2010 Dec 15;213(Pt 24):4232-9. doi: 10.1242/jeb.046318.

10.
11.

Neurotensin NTS1 and NTS2 receptor agonists produce anxiolytic-like effects in the 22-kHz ultrasonic vocalization model in rats.

Steele FF 3rd, Whitehouse SC, Aday JS, Prus AJ.

Brain Res. 2017 Mar 1;1658:31-35. doi: 10.1016/j.brainres.2017.01.012. Epub 2017 Jan 12.

PMID:
28089664
12.

Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand.

Held C, Plomer M, Hübner H, Meltretter J, Pischetsrieder M, Gmeiner P.

ChemMedChem. 2013 Jan;8(1):75-81. doi: 10.1002/cmdc.201200376. Epub 2012 Oct 24.

PMID:
23097347
13.

NT79: A novel neurotensin analog with selective behavioral effects.

Boules M, Liang Y, Briody S, Miura T, Fauq I, Oliveros A, Wilson M, Khaniyev S, Williams K, Li Z, Qi Y, Katovich M, Richelson E.

Brain Res. 2010 Jan 13;1308:35-46. doi: 10.1016/j.brainres.2009.10.050. Epub 2009 Oct 27.

14.

The amide linker in nonpeptide neurotensin receptor ligands plays a key role in calcium signaling at the neurotensin receptor type 2.

Thomas JB, Giddings AM, Olepu S, Wiethe RW, Warner KR, Sarret P, Longpre JM, Runyon SP, Gilmour BP.

Bioorg Med Chem Lett. 2015;25(10):2060-4. doi: 10.1016/j.bmcl.2015.03.083. Epub 2015 Apr 3.

15.

Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin Analogues.

Fanelli R, Besserer-Offroy É, René A, Côté J, Tétreault P, Collerette-Tremblay J, Longpré JM, Leduc R, Martinez J, Sarret P, Cavelier F.

J Med Chem. 2015 Oct 8;58(19):7785-95. doi: 10.1021/acs.jmedchem.5b00841. Epub 2015 Sep 16.

PMID:
26348111
16.

Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.

Da Costa G, Bondon A, Coutant J, Curmi P, Monti JP.

J Biomol Struct Dyn. 2013 Dec;31(12):1381-92. doi: 10.1080/07391102.2012.736776. Epub 2012 Nov 12. Erratum in: J Biomol Struct Dyn. 2014;32(1):170.

PMID:
23140271
17.

Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2.

Lee MR, Hinton DJ, Unal SS, Richelson E, Choi DS.

Alcohol Clin Exp Res. 2011 Jan;35(1):99-107. doi: 10.1111/j.1530-0277.2010.01326.x. Epub 2010 Oct 6.

18.

Structure-based evolution of subtype-selective neurotensin receptor ligands.

Schaab C, Kling RC, Einsiedel J, Hübner H, Clark T, Seebach D, Gmeiner P.

ChemistryOpen. 2014 Oct;3(5):206-18. doi: 10.1002/open.201402031. Epub 2014 Sep 23.

19.

The signaling signature of the neurotensin type 1 receptor with endogenous ligands.

Besserer-Offroy É, Brouillette RL, Lavenus S, Froehlich U, Brumwell A, Murza A, Longpré JM, Marsault É, Grandbois M, Sarret P, Leduc R.

Eur J Pharmacol. 2017 Jun 15;805:1-13. doi: 10.1016/j.ejphar.2017.03.046. Epub 2017 Mar 22.

PMID:
28341345
20.

NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization.

Perron A, Sharif N, Sarret P, Stroh T, Beaudet A.

Biochem Biophys Res Commun. 2007 Feb 16;353(3):582-90. Epub 2006 Dec 18.

PMID:
17188644

Supplemental Content

Support Center